Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

BIOLASE, Inc. (BIOL) Appoints Two To Senior Management Team

|Includes: Biolase, Inc. (BIOL)

BIOLASE is the world's leading dental laser manufacturer and distributor. The company's laser products incorporate about 290 patented and patent-pending technologies designed to have dentists perform procedures with less pain and faster recovery times. It also distributes and markets dental imaging equipment and other products that are focused on technologies that advance the practice of dentistry.

The company announced today two key appointments to its senior management team. Samir Chowdhury, Ph.D., has been appointed general manager, and Colleen Boswell has been appointed vice-president of regulatory affairs.

Dr. Chowdhury will primarily oversee the company's new product development and engineering efforts as well as assisting in developing strategic business plans. These may include creating new lines of business, marketing more broadly current technologies, and establishing new revenue streams. Previously, Dr. Chowdhury was general manager and COO at Gamma Medical, where he managed the clinical, pre-clinical, and industrial/space imaging operations. Prior experience also include stints as senior principal research scientist at Siemens Molecular and Imaging and Phillips Medical where he worked in R&D of new products. Eight of these products were awarded patents globally.

Ms. Boswell is an executive with experience in quality and regulatory compliance in high growth medical device companies. She will oversee and execute regulatory compliance initiatives for the firm, including filings and interactions with regulators. Before joining BIOLASE, Boswell worked at Sybron Dental Specialties, a Danaher company. She also worked previously in the biological division of the Alpha Therapetic Corporation and began her career at the Edwards CVS division of Baxter Healthcare Corporation.
The management additions are expected to help BIOLASE continue its efforts to grow the company's core dental product business. For further information about BIOLASE and its products, please visit the company's Web site at

Please see disclaimer on the MissionIR website